NewsBenzingaSELLAS Life Sciences anuncia datos preclínicos que demuestran la sinergia y la actividad de SLS009 en modelos de cáncer de páncreas amplificados por MYC SELLAS Life Sciences anuncia datos preclínicos que demuestran la sinergia y la actividad de SLS009 en modelos de cáncer de páncreas amplificados por MYC Benzinga 2026.09.25 17:03 (GMT+0) Open on Benzinga Other news Lennar Shares Jumped After Berkshire Hathaway Increased Its Position. How Investors Should View the Move. PYPL Stock Alert: What to Know as PayPal Takeover Rumors Restart Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his How to Play VRT Stock as Vertiv Acquires King Environmental Services Ahead of US IPO, British AI neocloud Nscale secures $3.36B in convertible financing Unusual Options Activity in Microsoft Stock Is Already Paying Off (and 3 Other Stocks to Watch)
Lennar Shares Jumped After Berkshire Hathaway Increased Its Position. How Investors Should View the Move.
